October 15, 2008

FDA conflict of interest in BPA

Here's more drama brewing in the world of bisphenol A (BPA).

A US Congressional committee, which has been investigating the BPA issue since January, is said to be investigating a possible instance of conflict of interest involving the chairman of the US Food and Drug Administration (FDA) advisory panel on BPA, Martin Philbert.

Philbert is said to be also the head of a research center that received a $5 million donation from Charles Gelman, a retired medical equipment manufacturer who has stated that BPA is “perfectly safe” and has also indicated that he has told Dr. Philbert of his opinion several times.

More on this post...
Post a Comment